ADM Addiction Treatment Modalities & Therapeutic Approaches 2

Question 1

Which pharmacotherapy is FDA-approved for treating alcohol use disorder by blocking opioid receptors to reduce craving and reward?

Accepted Answer

Naltrexone

Answer

Naltrexone is an opioid receptor antagonist FDA-approved for AUD that reduces alcohol craving and the reinforcing effects of alcohol.

Question 2

In Motivational Interviewing, the acronym OARS refers to which set of core communication skills?

Accepted Answer

Open questions, Affirmations, Reflective listening, Summarizing

Answer

OARS in Motivational Interviewing stands for Open questions, Affirmations, Reflective listening, and Summarizing — the four foundational communication techniques.

Question 3

A patient with opioid use disorder is started on buprenorphine/naloxone. When is the earliest it is generally safe to administer the first dose to avoid precipitated withdrawal?

Accepted Answer

When the patient shows mild-to-moderate withdrawal symptoms (COWS ≥8)

Answer

Buprenorphine induction should begin when the patient exhibits a COWS score of 8 or higher to prevent precipitating acute withdrawal.

Question 4

Which evidence-based behavioral therapy for addiction is based on operant conditioning principles and uses incentives to reinforce abstinence?

Accepted Answer

Contingency Management

Answer

Contingency Management uses tangible rewards (e.g., vouchers, prizes) contingent on verified abstinence, leveraging operant conditioning to reinforce drug-free behavior.

Question 5

Acamprosate (Campral) is thought to reduce alcohol craving primarily by modulating which neurotransmitter system?

Accepted Answer

Glutamatergic (NMDA) and GABAergic systems

Answer

Acamprosate is believed to restore balance in glutamatergic (NMDA receptor) and GABAergic neurotransmission disrupted by chronic alcohol use.

(ADM) Board Certified Addiction Medicine Specialist Practice Test

(ADM) Board Certified Addiction Medicine Specialist Practice Test

ADM Addiction Treatment Modalities & Therapeutic Approaches 2